Brief: Lee's Pharmaceutical Holdings Says Unit Successfully Completed Phase II Trial Of Cyclosporine A Ophthalmic Gel In China
30/10/2019 14:17
Oct 30 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UNIT SUCCESSFULLY COMPLETED A PHASE II TRIAL OF
CYCLOSPORINE A
(CSA) OPHTHALMIC GEL IN CHINA
* TOPLINE DATA SHOW EXPERIMENTAL DRUG HAS SIMILAR OR A TREND
TOWARDS BETTER EFFICACY THAN THAT OF MARKETED CSA OPHTHALMIC
EMULSION
* PLANS TO MEET WITH CENTER FOR DRUG EVALUATION IN CHINA TO
DISCUSS AND AGREE UPON A PHASE III PROTOCOL OF CSA OPHTHALMIC
GEL TRIAL
* PHASE III STUDY IS EXPECTED TO INITIATE PATIENT
RECRUITMENT IN
EARLY 2020
Source text for Eikon: ID:nHKSb3llfW
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals